Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Bandarsindri, Ajmer, Rajasthan-305817, India.
Pharmaceutics Division, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh 226031, Malaysia.
Curr Pharm Des. 2017;23(35):5315-5326. doi: 10.2174/1381612823666170829164828.
Delivery of chemotherapeutic drugs for the diagnosis and treatment of cancer is becoming advanced day by day. However, the challenge of the effective delivery system still does exist. In various types of cancers, breast cancer is the most commonly diagnosed cancer among women. Breast cancer is a combination of different diseases. It cannot be considered as only one entity because there are many specific patient factors, which are involved in the development of this disease. Nanotechnology has opened a new area in the effective treatment of breast cancer due to the several benefits offered by this technology.
Polymeric nanocarriers are among one of the effective delivery systems, which has given promising results in the treatment of breast cancers. Nanocarriers does exert their anticancer effect either through active or passive targeting mode.
The use of nanocarriers has been resolute about the adverse effects of chemotherapeutic drugs such as poor solubility and less penetrability in tumor cells.
The present review is focused on recent developments regarding polymeric nanocarriers, such as polymeric micelles, polymeric nanoparticles, dendrimers, liposomes, nanoshells, fullerenes, carbon nanotubes (CNT) and quantum dots, etc. for their recent advancements in breast cancer therapy.
用于癌症诊断和治疗的化疗药物的递送技术日益先进。然而,有效的递药系统仍然存在挑战。在各种类型的癌症中,乳腺癌是女性中最常见的癌症。乳腺癌是多种疾病的组合,不能仅视为一种实体,因为有许多特定的患者因素参与了这种疾病的发展。由于纳米技术提供了多种优势,因此在乳腺癌的有效治疗方面开辟了一个新的领域。
聚合物纳米载体是一种有效的递药系统,在乳腺癌的治疗中取得了有前景的效果。纳米载体通过主动或被动靶向模式发挥其抗癌作用。
纳米载体的使用解决了化疗药物的不良反应,如溶解度差和在肿瘤细胞中的穿透性差。
本综述集中讨论了聚合物纳米载体的最新进展,如聚合物胶束、聚合物纳米粒、树枝状大分子、脂质体、纳米壳、富勒烯、碳纳米管(CNT)和量子点等,它们在乳腺癌治疗方面的最新进展。